 Somatostatin analogue reduces glomerular filtration rate kidney size insulin-dependent diabetes treatment somatostatin analogue hyperfiltration hypertrophy insulin-dependent diabetes mellitus patients insulin-dependent diabetes mellitus glomerular hyperfiltration patients continuous subcutaneous infusion octreotide patients placebo patients weeks baseline mean glomerular filtration rate mean total kidney volume different groups weeks treatment mean glomerular filtration rate octreotide group mL/min range mL/min placebo group mL/min range mL/min mean total kidney volume treatment octreotide group range placebo group range Glycemic control group subcutaneous infusion octreotide weeks reduces glomerular filtration rate kidney size patients insulin-dependent diabetes fact glycemic control unchanged